NeuraMetrix
Overview
NeuraMetrix is a Software as a Medical Device (SaMD) company that provides a passive digital brain health biomarker called NeuraMetrix Typing Cadence (TC). This technology measures typing inconsistency to detect and monitor neurological diseases and psychiatric disorders. It is intended for use by researchers, physicians, and patients to obtain continuous and precise measurements of brain health.
- What it does:NeuraMetrix TC continuously measures typing cadence to detect and monitor neurological diseases and psychiatric disorders.
- Who it is for:The tool is for researchers, physicians, and patients involved in the care of individuals with neurological diseases and psychiatric disorders, including Alzheimer’s, Parkinson’s, Huntington’s, and Depression.
- How it fits a clinical or practice workflow:It offers a passive and continuous method for monitoring brain health, providing data that can be integrated into ongoing patient assessment and research.
- Notable capabilities:It can be sold globally for research purposes under Institutional Review Board (IRB) approval.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Passive digital brain health biomarker
- Measures typing inconsistency
- Detects neurological diseases
- Monitors neurological diseases
- Detects psychiatric disorders
- Monitors psychiatric disorders
- Continuous measurement of typing cadence
- Patented digital biomarker
- FDA-designated Breakthrough Device for Parkinson's Disease
- Provides precise and accurate measurements of brain health
Use Cases
- Detecting neurological diseases
- Monitoring neurological diseases
- Detecting psychiatric disorders
- Monitoring psychiatric disorders
- Research in neurological and psychiatric disorders
- Early detection of affective disorders
What Physicians Need to Know
NeuraMetrix offers a novel digital biomarker for detecting and monitoring neurological and psychiatric disorders through passive typing cadence measurement. This tool can provide continuous and precise data on brain health, potentially aiding in early detection and monitoring of conditions like Alzheimer's, Parkinson's, Huntington's, and depression. While designated a 'Breakthrough Device' by the US FDA for Parkinson's Disease, it is currently available for research under Institutional Review Board (IRB) approval.
The provided text does not specify details about LIS/LIMS integration, QC/QA features, critical value alerts, instrument interfaces, reference range intelligence, or microbiology ID support. The focus is on the proprietary Typing Cadence (TC) digital biomarker and its application in detecting and monitoring brain diseases.
Details
| Category | Lab & Diagnostics, Neurology AI, Wearables & Remote Monitoring (RPM) |
| Pricing | Unknown |
| Compliance | |
| BAA Available | Unknown |
| HIPAA Compliant | Unknown |
| FDA Status | Not applicable AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | Geriatrics, Neurology, Psychiatry |
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate NeuraMetrix
Videos
Product demos, reviews, and walkthroughs for NeuraMetrix.





